Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials
Michael Jason Nathenson, Lucy Hoch, Beth Ireland, Rose O’Nians Michalowicz, Dennis Williams, Neeta Somaiah · 2026
Read Pooled Analysis of Trabectedin Efficacy in Myxoid/Round Cell Liposarcoma from Three Prospective Clinical Trials by Michael Jason Nathenson, Lucy Hoch, Beth Ireland, Rose O’Nians Michalowicz, Dennis Williams, Neeta Somaiah (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13297495.txt.
Description
Simple SummaryTrabectedin is an effective, standard-of-care chemotherapy for recurrent or metastatic tumors after initial treatment for the soft tissue cancer, myxoid/round cell liposarcoma (MRCLS). It can replace more toxic agents used earlier to shrink tumors and improve response and survival in patients who have already received previous chemotherapy. Current benchmarks for trabectedin effectiveness are limited.
Catalog record
| CREATOR | Michael Jason Nathenson, Lucy Hoch, Beth Ireland, Rose O’Nians Michalowicz, Dennis Williams, Neeta Somaiah |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |